Cargando…
Effects of denosumab treatment in chronic liver disease patients with osteoporosis
BACKGROUND: Effective treatment of osteoporosis is essential for improving morbidity and health-related quality of life in chronic liver disease (CLD) patients. Denosumab has been shown to increase bone mineral density (BMD) and decrease the risk of osteoporotic fracture in the general population. H...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476181/ https://www.ncbi.nlm.nih.gov/pubmed/32952342 http://dx.doi.org/10.3748/wjg.v26.i33.4960 |